이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 1997. 7. 8.1 분 읽기
Medtronic, Inc.; Premarket Approval of the CapSureRegister Epi Pacing Lead, Model 4965
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is announcing its approval of the application submitted by Medtronic, Inc., Minneapolis, MN, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the CapSure Epi Pacing Lead, Model 4965. After reviewing the recommendation of the Circulatory System Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of September 6, 1996, of the approval of the application.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →